Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
The "Exosome Diagnostic and Therapeutics Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report ...
QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon ...
QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon and pancreatic cancers. New ...
The new report "Hematologic Malignancies Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2024–2032" has been added to the ...
The cult-favourite star told fans that he has to cancel several upcoming convention appearances for the summer.
Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.
FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
Genitourinary (GU) cancers, including prostate, bladder, renal and testicular malignancies, represent a heterogeneous group of diseases with varying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results